Monsenso AS Cash Flow Conversion Efficiency
Monsenso AS cash flow conversion efficiency. Based on the latest financial reports, Monsenso AS (MONSO) has a cash flow conversion efficiency ratio of -0.251x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-1.68 Million ≈ $-263.16K USD) by net assets (Dkr6.71 Million ≈ $1.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Monsenso AS (2016–2025)
Cash flow conversion efficiency of Monsenso AS from 2016 to 2025. This chart illustrates how Monsenso AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Monsenso AS stock price today for real-time trading data and today's change.
Monsenso AS Cash Flow Conversion Ratio Explained
Monsenso AS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Monsenso AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Monsenso AS ranked by their cash flow conversion efficiency. Also see market cap of Monsenso AS for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BuilderSmart Public Company Limited
BK:BSM
|
0.083x |
|
Techfast Holdings Bhd
KLSE:0084
|
0.129x |
|
Liminatus Pharma, Inc. Class A Common Stock
NASDAQ:LIMN
|
-3.227x |
|
Lakshmi Finance & Industrial Corporation Limited
NSE:LFIC
|
-0.054x |
|
HB Stockholdings Limited
NSE:HBSL
|
-0.126x |
|
Optima Prima Metal Sinergi
JK:OPMS
|
-0.014x |
|
E-Home Household Service Holdings Ltd
NASDAQ:EJH
|
0.004x |
|
Indo Pureco Pratama Tbk PT
JK:IPPE
|
0.000x |
Annual Cash Flow Conversion Efficiency for Monsenso AS (2016–2025)
The table below shows the annual cash flow conversion efficiency of Monsenso AS from 2016 to 2025. Review MONSO cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Dkr6.98 Million ≈ $1.09 Million |
Dkr-1.49 Million ≈ $-233.12K |
-0.214x | +56.98% |
| 2024-12-31 | Dkr14.16 Million ≈ $2.22 Million |
Dkr-7.03 Million ≈ $-1.10 Million |
-0.497x | -311.56% |
| 2023-12-31 | Dkr10.87 Million ≈ $1.70 Million |
Dkr2.55 Million ≈ $399.28K |
0.235x | +202.16% |
| 2022-12-31 | Dkr14.76 Million ≈ $2.31 Million |
Dkr-3.39 Million ≈ $-530.39K |
-0.230x | -12.40% |
| 2021-12-31 | Dkr21.44 Million ≈ $3.35 Million |
Dkr-4.38 Million ≈ $-685.75K |
-0.204x | -231.21% |
| 2020-12-31 | Dkr18.65 Million ≈ $2.92 Million |
Dkr2.91 Million ≈ $454.66K |
0.156x | +386.64% |
| 2019-12-31 | Dkr3.86 Million ≈ $604.55K |
Dkr-210.00K ≈ $-32.86K |
-0.054x | +91.70% |
| 2018-12-31 | Dkr3.82 Million ≈ $597.20K |
Dkr-2.50 Million ≈ $-390.99K |
-0.655x | -28.52% |
| 2017-12-31 | Dkr4.91 Million ≈ $767.42K |
Dkr-2.50 Million ≈ $-390.94K |
-0.509x | -32.62% |
| 2016-12-31 | Dkr6.51 Million ≈ $1.02 Million |
Dkr-2.50 Million ≈ $-390.94K |
-0.384x | -- |
About Monsenso AS
Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution,… Read more